Tapewire

Nasdaq · USD

PCRX

Pacira BioSciences, Inc.

Export transactions ↓
Tapewire entity
4928
SEC CIK
0001396814
Parsed reports
428

Last 12 months

Inside the activity.

0 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202502
Jan 202601
Feb 202602
Mar 202602
Apr 202604
May 202600
Jun 202602
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 08, 2022 Filed Jun 8, 2022 19:41 UTC
Reinhart Charles A. IIIChief Financial Officer
GrantCommon Stock 7,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035230 · doc4.xml · nonDerivative · entry 2

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,233

F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:26 UTC GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035222 · doc4.xml · derivative · entry 2

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:26 UTC GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035222 · doc4.xml · nonDerivative · entry 1

Greenstreet Yvonne · CIK 0001446125 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,247

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:46 UTC
WILLIAMS KRISTENChief Administrative Officer
GrantStock Option (Right to Buy) · Derivative 24,800 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035233 · doc4.xml · derivative · entry 4

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,800

Underlying: Common Stock · 24,800 shares

Expires 2032-06-08

F4 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:46 UTC
WILLIAMS KRISTENChief Administrative Officer
GrantCommon Stock 9,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035233 · doc4.xml · nonDerivative · entry 3

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,550

F3 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
GrantStock Option (Right to Buy) · Derivative 160,900 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · derivative · entry 10

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 160,900

Underlying: Common Stock · 160,900 shares

Expires 2032-06-08

F9 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
GrantCommon Stock 21,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · nonDerivative · entry 6

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 163,751

F7 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 501 $61.96 $31,041.96
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · nonDerivative · entry 5

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,251

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.89 to $62.24, inclusive.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 1,282 $61.31 $78,599.42
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · nonDerivative · entry 4

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 142,752

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.840 to $61.825, inclusive.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 5,006 $60.33 $302,011.98
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · nonDerivative · entry 3

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 144,034

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.83 to $60.82, inclusive.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 7,039 $59.10 $416,004.90
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · nonDerivative · entry 2

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 149,040

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.79 to $59.73, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 6.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:37 UTC
PACE GARY WDirector
GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035227 · doc4.xml · derivative · entry 2

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:37 UTC
PACE GARY WDirector
GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035227 · doc4.xml · nonDerivative · entry 1

PACE GARY W · CIK 0001184778 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,690

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:28 UTC GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035223 · doc4.xml · derivative · entry 2

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:28 UTC GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035223 · doc4.xml · nonDerivative · entry 1

HASTINGS PAUL J · CIK 0001309702 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,712

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:18 UTC
Brege LauraDirector
GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035215 · doc4.xml · derivative · entry 2

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:18 UTC
Brege LauraDirector
GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035215 · doc4.xml · nonDerivative · entry 1

Brege Laura · CIK 0001365619 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,147

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 24,800 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · derivative · entry 13

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,800

Underlying: Common Stock · 24,800 shares

Expires 2032-06-08

F13 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
GrantCommon Stock 9,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · nonDerivative · entry 11

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,060

F11 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:44 UTC
RIKER LAURENSenior Vice President, Finance
GrantStock Option (Right to Buy) · Derivative 14,600 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035231 · doc4.xml · derivative · entry 3

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,600

Underlying: Common Stock · 14,600 shares

Expires 2032-06-08

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:44 UTC
RIKER LAURENSenior Vice President, Finance
GrantCommon Stock 5,850 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035231 · doc4.xml · nonDerivative · entry 2

Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,852

F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:40 UTC
REINHARDT MAXPresident, Rest of World
GrantStock Option (Right to Buy) · Derivative 19,900 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035229 · doc4.xml · derivative · entry 4

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,900

Underlying: Common Stock · 19,900 shares

Expires 2032-06-08

F4 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:40 UTC
REINHARDT MAXPresident, Rest of World
GrantCommon Stock 7,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035229 · doc4.xml · nonDerivative · entry 3

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,250

F3 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:34 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
GrantStock Option (Right to Buy) · Derivative 19,900 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035226 · doc4.xml · derivative · entry 5

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,900

Underlying: Common Stock · 19,900 shares

Expires 2032-06-08

F6 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:34 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
GrantCommon Stock 7,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035226 · doc4.xml · nonDerivative · entry 4

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,950

F5 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
GrantStock Option (Right to Buy) · Derivative 24,800 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · derivative · entry 7

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,800

Underlying: Common Stock · 24,800 shares

Expires 2032-06-08

F8 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
GrantCommon Stock 9,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 6

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,752

F7 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
SaleCommon Stock 267 $61.98 $16,548.66
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 5

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,852

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.92 to $62.02, inclusive.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
SaleCommon Stock 516 $60.99 $31,470.84
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 4

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,119

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.80 to $61.41, inclusive.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
SaleCommon Stock 1,633 $60.23 $98,355.59
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 3

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,635

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.80 to $60.76, inclusive.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:39 UTC
LARANJEIRA CHARLES ANTHONYChief Technical Officer
SaleCommon Stock 2,521 $59.08 $148,940.68
Disclosure

SEC source: 0001209191-22-035228 · doc4.xml · nonDerivative · entry 2

LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,268

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.79 to $59.65, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 6.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:31 UTC
McLoughlin DennisChief Customer Officer
GrantStock Option (Right to Buy) · Derivative 19,900 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035225 · doc4.xml · derivative · entry 3

McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,900

Underlying: Common Stock · 19,900 shares

Expires 2032-06-08

F4 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:31 UTC
McLoughlin DennisChief Customer Officer
GrantCommon Stock 7,950 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035225 · doc4.xml · nonDerivative · entry 2

McLoughlin Dennis · CIK 0001752004 · Chief Customer Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,770

F3 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:29 UTC GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035224 · doc4.xml · derivative · entry 2

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:29 UTC GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035224 · doc4.xml · nonDerivative · entry 1

Kronenfeld Mark A. · CIK 0001578074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,897

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:20 UTC GrantStock Option (Right to Buy) · Derivative 8,225 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035216 · doc4.xml · derivative · entry 2

CHRISTIE CHRISTOPHER · CIK 0001787688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,225

Underlying: Common Stock · 8,225 shares

Expires 2032-06-08

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:20 UTC GrantCommon Stock 1,160 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035216 · doc4.xml · nonDerivative · entry 1

CHRISTIE CHRISTOPHER · CIK 0001787688 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,486

F1 · shares: Represents restricted stock units that vest on June 3, 2023, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:24 UTC
GAUGLER DARYLChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035221 · doc4.xml · derivative · entry 5

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2032-06-08

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:24 UTC
GAUGLER DARYLChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 19,800 $0.00 Strike: $59.39 $0.00
Disclosure

SEC source: 0001209191-22-035221 · doc4.xml · derivative · entry 4

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,800

Underlying: Common Stock · 19,800 shares

Expires 2032-06-08

F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:24 UTC
GAUGLER DARYLChief Operating Officer
GrantCommon Stock 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035221 · doc4.xml · nonDerivative · entry 3

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,394

F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 08, 2022 Filed Jun 8, 2022 23:24 UTC
GAUGLER DARYLChief Operating Officer
GrantCommon Stock 7,900 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-035221 · doc4.xml · nonDerivative · entry 2

GAUGLER DARYL · CIK 0001928278 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,394

F2 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 23:46 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 4,649 $59.51 $276,661.99
Disclosure

SEC source: 0001209191-22-035233 · doc4.xml · nonDerivative · entry 2

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,650

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 23:40 UTC
REINHARDT MAXPresident, Rest of World
SaleCommon Stock 2,433 $62.00 $150,846.00
Disclosure

SEC source: 0001209191-22-035229 · doc4.xml · nonDerivative · entry 2

REINHARDT MAX · CIK 0001780058 · President, Rest of World

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,400

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 23:34 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 1,830 $60.40 $110,532.00
Disclosure

SEC source: 0001209191-22-035226 · doc4.xml · nonDerivative · entry 3

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.07 to $60.88, inclusive.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 23:34 UTC
MOLLOY ANTHONYChief Lgl & Compliance Officer
SaleCommon Stock 740 $59.38 $43,941.20
Disclosure

SEC source: 0001209191-22-035226 · doc4.xml · nonDerivative · entry 2

MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,830

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.06 to $60.03, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:45 UTC
SLONIN JONATHANChief Clinical Officer
SaleCommon Stock 362 $61.37 $22,217.39
Disclosure

SEC source: 0001209191-22-035232 · doc4.xml · nonDerivative · entry 1

SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,197

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 19:41 UTC
Reinhart Charles A. IIIChief Financial Officer
SaleCommon Stock 2,516 $61.37 $154,416.98
Disclosure

SEC source: 0001209191-22-035230 · doc4.xml · nonDerivative · entry 1

Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,283

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:46 UTC
WILLIAMS KRISTENChief Administrative Officer
SaleCommon Stock 3,969 $61.37 $243,593.41
Disclosure

SEC source: 0001209191-22-035233 · doc4.xml · nonDerivative · entry 1

Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,299

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 19:51 UTC
STACK DAVID MDirector · CEO and Chairman
SaleCommon Stock 11,965 $61.37 $734,339.91
Disclosure

SEC source: 0001209191-22-035235 · doc4.xml · nonDerivative · entry 1

STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 156,079

F1 · shares: Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 23:48 UTC
WINSTON ROYChief Medical Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,250 $0.00 Strike: $34.38 $0.00
Disclosure

SEC source: 0001209191-22-035234 · doc4.xml · derivative · entry 12

WINSTON ROY · CIK 0001751757 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2028-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.